|
Market Cap | 52.61M | EPS (ttm) | -0.08 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 0.76 | EPS next 5Y | - |
P/B | 5.48 | EPS Q/Q | 57.51% |
Dividend | - | Sales Q/Q | 28.82% |
Insider Own | 88.01% | Inst Own | 0.05% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.98% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 113.59K | 52W Range | 1.01 - 4.18 |
|
|
|
Primech Holdings Ltd. engages in the provision of commercial cleaning solutions. Its cleaning services caters to conservancy areas, educational institutions, airports, facilities, and exteriors of buildings. The company was founded on December 29, 2020 and is headquartered in Singapore. |
|
|
|
Market Cap | 15.74M | EPS (ttm) | -1.67 |
P/E | - | EPS this Y | 65.08% |
Forward P/E | - | EPS next Y | 24.26% |
PEG | - | EPS past 5Y | -13.77% |
P/S | 0.22 | EPS next 5Y | 20.00% |
P/B | 0.81 | EPS Q/Q | -3.69% |
Dividend | - | Sales Q/Q | -13.40% |
Insider Own | 33.73% | Inst Own | 21.99% |
Insider Trans | 0.00% | Inst Trans | 8.12% |
Short Float | 2.05% | Earnings | Mar 27/a |
Analyst Recom | 1.00 | Target Price | 4.74 |
Avg Volume | 109.31K | 52W Range | 1.00 - 2.98 |
|
|
Today 08:39AM
|
Why Is Urban-gro (UGRO) Stock Down 18% Today?
(InvestorPlace) -25.69% |
Mar-27-24 08:53PM
|
UGRO Stock Earnings: Urban-gro Misses EPS, Misses Revenue for Q4 2023
(InvestorPlace) -6.92% |
04:05PM
|
urban-gro, Inc. Reports 2023 Financial Results and Provides Outlook on 2024 Performance
(ACCESSWIRE) |
Mar-13-24 08:00AM
|
urban-gro, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 27, 2024
(ACCESSWIRE) +6.12% |
Jan-06-24 06:30AM
|
Urban Farming Frontiers: 3 Stocks Growing Greens in the City
(InvestorPlace) |
Jan-02-24 08:15AM
|
urban-gro, Inc. Secures Design-Build Contract Valued at Approximately $20 Million
(GlobeNewswire) |
Dec-18-23 08:15AM
|
urban-gro, Inc. Finalizes $10 Million Interest-Only Revolving Asset-Based Lending Facility
(GlobeNewswire) |
Nov-30-23 09:05AM
|
urban-gro, Inc. Awarded $9.6 Million Industrial Design-Build Contract with Existing CPG Client
(GlobeNewswire) |
Nov-13-23 11:05AM
|
urban-gro, Inc. (NASDAQ:UGRO) Q3 2023 Earnings Call Transcript
(Insider Monkey) -5.22% |
Nov-09-23 04:05PM
|
urban-gro, Inc. Reports Third Quarter 2023 Financial Results Demonstrating Sequential Improvement in Revenue, Backlog, and Adjusted EBITDA
(GlobeNewswire) |
|
Urban-Gro, Inc. is an agricultural technology systems integrator. The firm engages in manufacturing, distributing, and selling lighting, pest management, fertigation, and water and other products to the medical and recreational cannabis industry in states where operation of a cannabis production facility has been legalized. It also provides full design and expertise on climate and automated control of fertigation and irrigation systems, lighting systems, environmental, substrate and inventory monitoring, water treatment systems, and integrated pest management solutions. The company was founded by Bradley J. Nattrass and Octavio Gutierrez on March 20, 2014 and is headquartered in Lafayette, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
WILKS LEWIS | Director | Aug 30 '23 | Buy | 1.03 | 10,000 | 10,300 | 126,306 | Sep 01 07:51 AM | WILKS LEWIS | Director | Jun 12 '23 | Buy | 1.40 | 10,000 | 13,969 | 116,306 | Jun 12 05:22 PM | Nattrass Bradley John | Chief Executive Officer | Jun 09 '23 | Buy | 1.25 | 28,416 | 35,449 | 1,900,000 | Jun 12 05:55 PM | WILKS LEWIS | Director | May 19 '23 | Buy | 1.60 | 10,000 | 16,025 | 106,306 | May 22 04:57 PM | Lowe James Robert | Director | May 18 '23 | Buy | 1.89 | 25,000 | 47,225 | 423,410 | May 18 07:35 PM |
|
|
|
|
Market Cap | 40.76M | EPS (ttm) | -0.39 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -208.54% |
P/S | 1.65 | EPS next 5Y | - |
P/B | 2.05 | EPS Q/Q | 168.61% |
Dividend | - | Sales Q/Q | 35.47% |
Insider Own | 44.43% | Inst Own | 9.12% |
Insider Trans | 0.00% | Inst Trans | 6.77% |
Short Float | 6.73% | Earnings | Mar 28/b |
Analyst Recom | 1.00 | Target Price | 9.00 |
Avg Volume | 120.76K | 52W Range | 1.60 - 7.65 |
|
|
|
Data Storage Corp. engages in the provision of business continuity services. These services include disaster recovery, infrastructure as a service, and cyber security. Its other services and solutions include data protection services, data center and security, voice and data solutions, and email archival solutions. The company was founded by Charles M. Piluso in June 2001 and is headquartered in Melville, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Argen John | Director | Dec 26 '23 | Option Exercise | 2.04 | 833 | 1,699 | 16,667 | Jan 03 08:57 PM |
|
|
| |
|
Market Cap | 318.49M | EPS (ttm) | -5.18 |
P/E | - | EPS this Y | 60.78% |
Forward P/E | - | EPS next Y | 47.52% |
PEG | - | EPS past 5Y | -53.05% |
P/S | - | EPS next 5Y | 12.40% |
P/B | 1.05 | EPS Q/Q | 35.29% |
Dividend | - | Sales Q/Q | - |
Insider Own | 7.36% | Inst Own | 76.91% |
Insider Trans | 0.00% | Inst Trans | 2.83% |
Short Float | 4.16% | Earnings | Mar 28/a |
Analyst Recom | 3.00 | Target Price | 2.83 |
Avg Volume | 825.07K | 52W Range | 1.37 - 9.80 |
|
|
|
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
BORGESON JOHN A. | See Remarks | Jun 16 '23 | Sale | 9.23 | 2,749 | 25,373 | 178,077 | Jun 16 08:25 PM | EHRLICH JASON | See Remarks | Jun 16 '23 | Sale | 9.23 | 2,258 | 20,841 | 61,924 | Jun 16 08:27 PM | BORGESON JOHN A. | See Remarks | Jun 14 '23 | Sale | 9.42 | 1,448 | 13,640 | 175,332 | Jun 16 08:25 PM | EHRLICH JASON | See Remarks | Jun 14 '23 | Sale | 9.42 | 1,132 | 10,663 | 58,688 | Jun 16 08:27 PM |
|
|
|
|
Market Cap | 1.82B | EPS (ttm) | 0.97 |
P/E | 25.79 | EPS this Y | 8.38% |
Forward P/E | 11.44 | EPS next Y | 9.10% |
PEG | 0.86 | EPS past 5Y | -23.57% |
P/S | 0.49 | EPS next 5Y | 30.00% |
P/B | 1.29 | EPS Q/Q | 5560.38% |
Dividend | 3.00% | Sales Q/Q | -11.41% |
Insider Own | 1.03% | Inst Own | 89.74% |
Insider Trans | -1.29% | Inst Trans | -0.92% |
Short Float | 3.15% | Earnings | Mar 27/a |
Analyst Recom | 3.00 | Target Price | 33.50 |
Avg Volume | 812.94K | 52W Range | 13.20 - 31.33 |
|
|
|
MillerKnoll, Inc. engages in the research, design, manufacture, and distribution of interior furnishings. It operates through the following business segments: Americas Contract (Americas), International Contract and Specialty, Global Retail (Retail), and Corporate. The Americas segment refers to the operations associated with the design, manufacture, and sale of furniture products throughout North and South America. The International Contract and Specialty segment includes the operations associated with the design, manufacture, and sale of furniture products through an independent dealership network in Europe, the Middle East, Africa, and Asia-Pacific. The Retail segment is involved in the global operations associated with the sale of modern design furnishings and accessories to third party retailers. The Corporate segment relates to general corporate functions, including, but not limited to, certain legal, executive, corporate finance, information technology, administrative, and acquisition-related costs. The company was founded by Dirk Jan de Pree and Kevin J. Veltman in 1905 and is headquartered in Zeeland, MI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Baldwin Christopher M | Group President | Feb 16 '24 | Option Exercise | 0.00 | 11,459 | 0 | 38,545 | Feb 20 12:55 PM | Michael John P | President Americas Cntrct | Jan 14 '24 | Option Exercise | 0.00 | 739 | 0 | 9,912 | Jan 19 07:26 PM | Stutz Jeffrey M | Chief Fincl Officer | Dec 22 '23 | Sale | 28.23 | 9,771 | 275,836 | 35,622 | Dec 22 04:54 PM | BRANDON DAVID | Director | Oct 16 '23 | Option Exercise | 0.00 | 9,029 | 0 | 25,838 | Oct 18 09:25 PM | Stutz Jeffrey M | Chief Fincl Officer | Aug 01 '23 | Option Exercise | 0.00 | 12,977 | 0 | 47,583 | Aug 03 09:26 PM |
|
|
| |
|
Market Cap | 964.92M | EPS (ttm) | -0.92 |
P/E | - | EPS this Y | 16.22% |
Forward P/E | - | EPS next Y | 57.35% |
PEG | - | EPS past 5Y | - |
P/S | 0.20 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -213.80% |
Dividend | - | Sales Q/Q | 11.45% |
Insider Own | 0.34% | Inst Own | 28.82% |
Insider Trans | 0.00% | Inst Trans | -12.26% |
Short Float | 13.85% | Earnings | Feb 28/a |
Analyst Recom | 3.86 | Target Price | 5.02 |
Avg Volume | 13.97M | 52W Range | 3.59 - 54.97 |
|
|
|
AMC Entertainment Holdings, Inc. engages in the theatrical exhibition business through its subsidiaries. It operates through the U.S. Markets and International Markets segments. The U.S. Markets segment is involved in owning, leasing, or operating theaters and screens in the U.S. The International Markets segment focuses on owning, leasing, or operating theaters and screens in the United Kingdom, Germany, Spain, Italy, Ireland, Portugal, Sweden, Finland, Norway, Denmark, and Saudi Arabia. The company was founded by Barney Dubinsky, Maurice Durwood and Edward Durwood in 1920 and is headquartered in Leawood, KS. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
CHAVARRIA CARLA C | SVP, Chief HR Officer | Jan 02 '24 | Option Exercise | 0.00 | 10,107 | 0 | 57,096 | Jan 10 04:34 PM | FRANK ELIZABETH F | EVP CHIEF PROGRAM OFFICER | Jan 02 '24 | Option Exercise | 0.00 | 13,358 | 0 | 35,376 | Jan 10 05:18 PM | ELLIS DANIEL E | EVP, Chief Ops & Dev Officer | Jan 02 '24 | Option Exercise | 0.00 | 11,880 | 0 | 30,185 | Jan 10 05:26 PM | CONNOR KEVIN M | SVP GENERAL COUNSEL & SEC | Jan 02 '24 | Option Exercise | 0.00 | 10,543 | 0 | 27,857 | Jan 10 05:32 PM | ARON ADAM M | Chairman, President & CEO | Jan 02 '24 | Option Exercise | 0.00 | 126,328 | 0 | 492,664 | Jan 10 05:42 PM |
|
|
|
|
Market Cap | 327.65M | EPS (ttm) | -0.16 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 11.74 | EPS Q/Q | -190.67% |
Dividend | - | Sales Q/Q | - |
Insider Own | 64.04% | Inst Own | 39.63% |
Insider Trans | 0.00% | Inst Trans | -45.92% |
Short Float | 0.23% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 113.95K | 52W Range | 6.20 - 56.00 |
|
|
|
Concord Acquisition Corp. III is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more entities. The company was founded on February 18, 2021 and is headquartered in New York, NY. |
|
| |
|
Market Cap | 7.26M | EPS (ttm) | -0.86 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 38.52% |
P/S | 0.11 | EPS next 5Y | - |
P/B | 1.98 | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 39.45% | Inst Own | 0.00% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.92% | Earnings | Oct 02/b |
Analyst Recom | - | Target Price | - |
Avg Volume | 55.50K | 52W Range | 1.40 - 16.40 |
|
|
|
Antelope Enterprise Holdings Ltd. engages in the manufacture and sale of ceramics tiles. Its products operates through the Hengda, the Hengdeli or HDL brand, TOERTO, WULIQIAO, and Pottery Capital of Tang Dynasty brands. It offers porcelain, glazed, glazed porcelain, rustic, and polished glazed tiles. The company was founded by Jia Dong Huan on September 30, 1993 and is headquartered in Chengdu, China. |
|
|
|
Market Cap | 118.00M | EPS (ttm) | -0.92 |
P/E | - | EPS this Y | 57.61% |
Forward P/E | - | EPS next Y | 51.28% |
PEG | - | EPS past 5Y | -879.48% |
P/S | 0.36 | EPS next 5Y | - |
P/B | 2.08 | EPS Q/Q | -40.81% |
Dividend | - | Sales Q/Q | 20.11% |
Insider Own | 58.17% | Inst Own | 20.37% |
Insider Trans | -0.12% | Inst Trans | 0.95% |
Short Float | 0.76% | Earnings | Mar 27/a |
Analyst Recom | 1.00 | Target Price | 2.50 |
Avg Volume | 137.18K | 52W Range | 0.33 - 2.65 |
|
|
|
The Oncology Institute, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Havencrest Healthcare Partners | 10% Owner | Jan 29 '24 | Sale | 2.12 | 8,637 | 18,310 | 0 | Jan 30 07:07 PM | Havencrest Healthcare Partners | 10% Owner | Jan 26 '24 | Sale | 2.14 | 6,979 | 14,935 | 8,637 | Jan 26 07:19 PM | Havencrest Healthcare Partners | 10% Owner | Jan 25 '24 | Sale | 2.07 | 11,882 | 24,596 | 15,616 | Jan 26 07:19 PM | Havencrest Healthcare Partners | 10% Owner | Jan 24 '24 | Sale | 2.30 | 24,915 | 57,304 | 27,498 | Jan 26 07:19 PM | Havencrest Healthcare Partners | 10% Owner | Jan 23 '24 | Sale | 2.11 | 5,338 | 11,263 | 52,413 | Jan 23 08:02 PM |
|
|
|
|
Market Cap | 19.26M | EPS (ttm) | -9.20 |
P/E | - | EPS this Y | 32.75% |
Forward P/E | - | EPS next Y | 31.49% |
PEG | - | EPS past 5Y | 6.21% |
P/S | 7.86 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 40.60% |
Dividend | - | Sales Q/Q | 836.61% |
Insider Own | 17.25% | Inst Own | 14.12% |
Insider Trans | 0.00% | Inst Trans | 103.52% |
Short Float | 5.54% | Earnings | Mar 27/b |
Analyst Recom | 2.00 | Target Price | 4.00 |
Avg Volume | 74.95K | 52W Range | 1.60 - 8.07 |
|
|
|
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. Its products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. The company was founded on June 26, 2014 and is headquartered in New York, NY. |
|
|